<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Database (Oxford)</journal-id>
    <journal-id journal-id-type="iso-abbrev">Database (Oxford)</journal-id>
    <journal-id journal-id-type="publisher-id">databa</journal-id>
    <journal-title-group>
      <journal-title>Database: The Journal of Biological Databases and Curation</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-0463</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
      <publisher-loc>UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8730286</article-id>
    <article-id pub-id-type="pmid">34964846</article-id>
    <article-id pub-id-type="doi">10.1093/database/baab075</article-id>
    <article-id pub-id-type="publisher-id">baab075</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00960</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>The first comprehensive database of germline pathogenic variants in East
Asian cancer patients</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Shi</surname>
          <given-names>Xiaoshun</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
        <aff><institution content-type="department">Harry Perkins Institute of Medical Research, QEII
Medical Centre and Centre for Medical Research, The University of Western
Australia</institution>, 6 Verdun St, Nedlands WA 6009, <country country="AU">Australia</country></aff>
        <xref rid="fn1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4822-2898</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Ruidong</given-names>
        </name>
        <aff><institution content-type="department">Genetics, Genomics, and Bioinformatics Program,
University of California</institution>, 900 University Ave, Riverside, CA 92507,
<country country="US">USA</country></aff>
        <xref rid="fn1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhai</surname>
          <given-names>Jianxue</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
        <xref rid="fn1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Allen Menglin</given-names>
        </name>
        <aff><institution>Guangzhou Mendel Genomics and Medical Technology Co., Ltd.</institution>,
6/F, Bldg D, 188 Kaiyuan Ave, Guangzhou 510535, <country country="CN">P. R.
China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Kailing</given-names>
        </name>
        <aff><institution>Guangzhou Mendel Genomics and Medical Technology Co., Ltd.</institution>,
6/F, Bldg D, 188 Kaiyuan Ave, Guangzhou 510535, <country country="CN">P. R.
China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zheng</surname>
          <given-names>Zhouxia</given-names>
        </name>
        <aff><institution>Guangzhou Mendel Genomics and Medical Technology Co., Ltd.</institution>,
6/F, Bldg D, 188 Kaiyuan Ave, Guangzhou 510535, <country country="CN">P. R.
China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Zhuona</given-names>
        </name>
        <aff><institution>Guangzhou Mendel Genomics and Medical Technology Co., Ltd.</institution>,
6/F, Bldg D, 188 Kaiyuan Ave, Guangzhou 510535, <country country="CN">P. R.
China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Dong</surname>
          <given-names>Xiaoyin</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Xiguang</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lu</surname>
          <given-names>Di</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feng</surname>
          <given-names>Siyang</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Diao</surname>
          <given-names>Dingwei</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ren</surname>
          <given-names>Pengfei</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Zhaoguo</given-names>
        </name>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morahan</surname>
          <given-names>Grant</given-names>
        </name>
        <!--grant.morahan@uwa.edu.au-->
        <aff><institution content-type="department">Harry Perkins Institute of Medical Research, QEII
Medical Centre and Centre for Medical Research, The University of Western
Australia</institution>, 6 Verdun St, Nedlands WA 6009, <country country="AU">Australia</country></aff>
        <xref rid="COR0001" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4664-6694</contrib-id>
        <name>
          <surname>Cai</surname>
          <given-names>Kaican</given-names>
        </name>
        <!--doc_cai@163.com-->
        <xref rid="COR0001" ref-type="corresp"/>
        <aff><institution content-type="department">Department of Thoracic Surgery, Nanfang Hospital,
Southern Medical University</institution>, 1838 Guang Zhou Avenue North, Guangzhou
510515, <country country="CN">P. R. China</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR0001">*Correspondence may also be addressed to Kaican Cai. Tel:
+020-62786460; E-mail: <email xlink:href="doc_cai@163.com">doc_cai@163.com</email> and Grant Morahan. Tel:
+61-861510756; E-mail: <email xlink:href="grant.morahan@uwa.edu.au">grant.morahan@uwa.edu.au</email></corresp>
      <fn id="fn1">
        <label>#</label>
        <p>Xiaoshun Shi,Ruidong Li and Jianxue Zhai contributed equally and are considered
co-first authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-12-29">
      <day>29</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <volume>2021</volume>
    <elocation-id>baab075</elocation-id>
    <history>
      <date date-type="received">
        <day>27</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>29</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>26</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>21</day>
        <month>10</month>
        <year>2021</year>
      </date>
      <date date-type="corrected-typeset">
        <day>29</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University
Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted
reuse, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="baab075.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Pathogenic germline variants in cancer-associated genes are risk factors for cancer
predisposition. However, systematic mining and summarizing of cancer pathogenic or
likely pathogenic variants has not been performed for people of East Asian descent. This
study aimed to investigate publicly available data to identify germline variants in East
Asian cancer cohorts and compare them to variants in Caucasian cancer cohorts. Based on
the data we retrieved, we built a comprehensive database, named COGVIC (Catalog of
Germline Variants in Cancer). A total of 233 variants in the East Asian population were
identified. The majority (87%) of genes with cancer-associated variants were not shared
between the East Asian and Caucasian cohorts. This included pathogenic variants in
<italic toggle="yes">BRCA2</italic>. Our study summarized the prevalence of germline variants in
East Asian cancer cohorts and provides an easy-to-use online tool to explore germline
mutations related to cancer susceptibility.</p>
      <sec id="s2">
        <title>Database URL</title>
        <p>
          <ext-link xlink:href="http://www.cogvic.vip/" ext-link-type="uri">http://www.cogvic.vip/</ext-link>
        </p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>the Science and Technology Program of Guangzhou</institution>
          </institution-wrap>
        </funding-source>
        <award-id>201903010003</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>the Major Science and Technology Planning Project of Guangdong
Province</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2017B020226005</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>the Research Initiative Fund of Southern Hospital 2018</institution>
          </institution-wrap>
        </funding-source>
        <award-id>C1051325</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>the National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>81902319</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="9"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec id="s3">
    <title>Introduction</title>
    <p>With the increasing application of next-generation sequencing (NGS) in basic research
(<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>) and
clinical studies (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>), it is evident that NGS is a useful approach to investigate germline variants
that predispose people to cancer. Although the number of germline variants associated with
cancer susceptibility has expanded (<xref rid="R5" ref-type="bibr">5</xref>) and a
considerable amount of exon sequencing data from tumor and tumor-matched control tissues are
publicly available (<xref rid="R6" ref-type="bibr">6</xref>), systematic mining and
summarizing of these pathogenic or likely pathogenic variants has not yet been
performed.</p>
    <p>Tumor susceptibility may differ between ethnic groups due to genetic differences (<xref rid="R7" ref-type="bibr">7</xref>). The Cancer Genome Atlas (TCGA) cooperative group
provides large-scale cancer NGS data and predisposition variants in cancer (<xref rid="R1" ref-type="bibr">1</xref>), but the majority of its samples are from Caucasian
subjects. Therefore, using the current TCGA data as a reference for cancer genetic
comparisons in the East Asian population may be insufficient at best and even misleading due
to underlying genetic differences between these populations.</p>
    <p>To address this issue, we performed a comprehensive investigation of germline mutations in
current genomic datasets, aiming to provide references for cancer genetic consulting for
patients with ancestry from the East Asian geographical regions. We developed a novel
germline mutation identifier for NGS data, established an online tool for germline mutation
retrieval, described the prevalence of germline mutations in the East Asian population, and
compared the prevalence of <italic toggle="yes">BRCA2</italic> hotspot variants in a larger worldwide
population.</p>
  </sec>
  <sec id="s4">
    <title>Materials and methods</title>
    <sec id="s4-s1">
      <title>Data collection</title>
      <p>A comprehensive collection of NGS data released between 2012 and 2019 was obtained from
NCBI SRA (Sequence Read Archive, <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/sra/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/sra/</ext-link>), EBI (European Nucleotide Archive,
<ext-link xlink:href="https://www.ebi.ac.uk/ena" ext-link-type="uri">https://www.ebi.ac.uk/ena</ext-link>) and DDBJ
SRA (DNA Data Bank of Japan, <ext-link xlink:href="https://www.ddbj.nig.ac.jp/dra/index-e.html" ext-link-type="uri">https://www.ddbj.nig.ac.jp/dra/index-e.html</ext-link>). We also screened data from
published sources, TCGA, and the International Cancer Genomics Consortium program. Only
Illumina NGS datasets where raw data were available, including whole-genome sequencing
(WGS), whole-exome sequencing (WES), and RNA sequencing (RNA-Seq) libraries, were
included. Only studies that were approved by the original institutional review board were
included. All data used were checked by scientists with a background in biology and
confirmed by licensed doctors to ensure that they were derived from tumor studies. Data
generated from normal samples, including peripheral blood and tumor-matched tissue, were
first identified and then retrieved for subsequent in-house germline variant analysis.
Based on data availability, the East Asian population in this study was defined as the
eastern subregion of Asia, including China, Japan, Korea, and Vietnam.</p>
    </sec>
    <sec id="s4-s2">
      <title>Development of a pipeline for variant identification</title>
      <p>In this study, ‘variants’ included both single-nucleotide polymorphisms and insertion or
deletion sequences (indels). A variant-identifying workflow named the ‘COGVIC ((Catalog Of
Germline Variants In Cancer) analysis pipeline’ was developed for a comprehensive analysis
to obtain a list of East Asian cancer-caused germline mutations.</p>
      <sec id="s4-s2-s1">
        <title>Data quality control and preprocessing</title>
        <p>FastQC software (<xref rid="R8" ref-type="bibr">8</xref>) was used for quality control
of the raw sequencing data with default parameters. Adapter sequences and low-quality
nucleotides were trimmed and filtered using Trim Galore software (version) (<xref rid="R9" ref-type="bibr">9</xref>) with the following parameters: -q 25—phred33—length
36—stringency 3—paired. The quality control step was run again on the cleaned data.</p>
      </sec>
      <sec id="s4-s2-s2">
        <title>DNA data alignment and variant identification</title>
        <p>For the genomics data generated with WGS-based, WES-based, and target-based
technologies, alignment to the hg19/GRCH37 genome was performed with Bowtie2 software
with the default settings (<xref rid="R10" ref-type="bibr">10</xref>). After stringent
quality assessment and data filtering, reads with mapping quality greater than 20 were
selected as high-quality reads for further analysis. Variants were detected with Varscan
(—output-vcf 1—variants) based on a <italic toggle="yes">P</italic>-value of 0.01 (<xref rid="R11" ref-type="bibr">11</xref>).</p>
      </sec>
      <sec id="s4-s2-s3">
        <title>RNA data alignment and variant identification</title>
        <p>FastQC software was used for low-quality RNA-seq data filtering (<xref rid="R8" ref-type="bibr">8</xref>). STAR software (<xref rid="R12" ref-type="bibr">12</xref>) was used
for RNA-seq data alignment to the GRCH38/hg38 reference genome. GATK was used for
variant identification and detected with GATK (version 3.6.0).</p>
      </sec>
      <sec id="s4-s2-s4">
        <title>Variant quality control</title>
        <p>For each of the alignment results, an indexed BAM file was generated using SAMtools
(<xref rid="R13" ref-type="bibr">13</xref>). Each BAM file was provided as input to
each variant caller to generate a VCF file of unfiltered variant calls. To remove
low-quality variants, genotypes were required to have DP &gt;6, and all variants with
quality scores of less than 40 were removed. To obtain further filtered variant calls,
GATK was run through variant quality score recalibration steps (VQSR), as documented at
the Broad Institute website (<ext-link xlink:href="https://www.broadinstitute.org/gatk/guide/article?id=2805" ext-link-type="uri">https://www.broadinstitute.org/gatk/guide/article?id=2805</ext-link>). Variants that
passed both quality filters, i.e. those flagged as PASS in the GATK VQSR Filter, were
used for the downstream analysis, including annotation and clinical interpretation.</p>
      </sec>
      <sec id="s4-s2-s5">
        <title>Variant filtration and annotation</title>
        <p>The annotation step was conducted with ANNOVAR (<xref rid="R14" ref-type="bibr">14</xref>) command for each subject (table_annovar.pl annovar/humandb -buildver
hg19—remove—protocol refGene, avsnp150,1000g2015aug_all,1000g2015aug_eas,
gnomad_exome_20190125,clinvar_20181225 -operation g, f, f, f,f,f). As common variants
are usually easy to detect, we used ANNOVAR to filter the variants by minor allele
frequency (MAF). All filtered and annotation criteria are listed below:</p>
        <list list-type="roman-lower">
          <list-item>
            <p>Variants with MAF &gt; 1% (GnomAD project, v2.1, 2018 release, East Asian
population) were discarded.</p>
          </list-item>
          <list-item>
            <p>Synonymous, nonsplicing or nonexonic variants were discarded.</p>
          </list-item>
          <list-item>
            <p>Damaging missense mutations were defined as deleterious by at least two of the
following criteria based on several function prediction models: SIFT (Sorting
Intolerant From Tolerant) score ≤0.05, Polyphen2(HDIV) score ≥0.95, Mutation
Assessor ≥2, Phred transformed CADD (Combined Annotation-Dependent Depletion) score
≥15, placental mammal PhyloP ≥ 2.4,and vertebrate PhyloP ≥4.</p>
          </list-item>
          <list-item>
            <p>Since we incorporated variants from clinical databases, such as ClinVar, COSMIC,
TCGA, and OMIM, those variants associated with a phenotype (such as a disease or
risk factor for a cancer-related disease) were kept for our final mutation list.</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s4-s3">
      <title>Functional gene set analysis</title>
      <p>We explored the key functions of the gene set mapped with pathogenic or likely pathogenic
variants using g:Profiler (<ext-link xlink:href="https://biit.cs.ut.ee/gprofiler/gost" ext-link-type="uri">https://biit.cs.ut.ee/gprofiler/gost</ext-link>). The top 10 GO and KEGG pathways were
plotted using the ggplot2 package in R.</p>
    </sec>
    <sec id="s4-s4">
      <title>Online database</title>
      <p>The online database was developed based on the widely used MediaWiki package. System
requirements of MediaWiki are PHP 7.4.9+ and either MySQL 5.5.8+, MariaDB, SQLite or
PostgreSQL.</p>
    </sec>
  </sec>
  <sec id="s5">
    <title>Results</title>
    <sec id="s5-s1">
      <title>Study design</title>
      <p>We accessed the SRA database, excluding irrelevant items (e.g. noncancer study library
construction strategies not related to RNA sequencing, WES or whole genome sequencing and
non-Illumina HiSeq sequencing instruments) (<xref rid="F1" ref-type="fig">Figure
1A</xref>). In addition, data from non-East Asian populations and data without
tumor-matched controls were removed by manually reviewing the abstract or full text of
each publicly available article or other data documentation. This process yielded 73
studies with WGS and WES data (<xref rid="F1" ref-type="fig">Figure 1B</xref>). The
datasets available for analysis were mainly from Singapore, Korea, and China (the COGVIC
database, download page). A total of 1 677 337 entries and 2112 eligible studies with
89 152 sequencing items were collected.</p>
      <fig position="float" id="F1" fig-type="figure">
        <label>Figure 1.</label>
        <caption>
          <p>The COGVIC workflow of data selection and germline variant identification. (A) A
total of 1 677 337 SRA entries with 17 545 study accessions were filtered out based on
the inclusion criteria. (B) The pipeline of the COGVIC germline variant
identifier.</p>
        </caption>
        <graphic xlink:href="baab075f1" position="float"/>
      </fig>
    </sec>
    <sec id="s5-s2">
      <title>Clinical characteristics of patients in the included studies</title>
      <p>Across these 73 studies, the average onset age was 54, ranging from 10 months to 85 years
(in comparison, the TCGA cohort (<xref rid="R5" ref-type="bibr">5</xref>) established a
diagnosis between 10 and 90 years of age). The COGVIC analysis workflow revealed a total
of 233 potential cancer-causing germline variants (COGVIC variants) from 2401
tumor-matched normal samples across 20 types of cancer and 2 precancerous lesions. The
cancer types and lesions with mutation frequencies in each group are listed in <xref rid="T1" ref-type="table">Table 1</xref>.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1.</label>
        <caption>
          <p>The frequency of cancer pathogenic variants in the East Asian population</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Cancer</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Mutation frequency</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Mutation cases/number of samples</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Esophageal squamous cell carcinoma</td>
              <td align="left" rowspan="1" colspan="1">9.1%</td>
              <td align="left" rowspan="1" colspan="1">42/464</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Gastric carcinoma</td>
              <td align="left" rowspan="1" colspan="1">11.1%</td>
              <td align="left" rowspan="1" colspan="1">26/234</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Nasopharyngeal carcinoma</td>
              <td align="left" rowspan="1" colspan="1">12.6%</td>
              <td align="left" rowspan="1" colspan="1">26/206</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Breast carcinoma</td>
              <td align="left" rowspan="1" colspan="1">16.8%</td>
              <td align="left" rowspan="1" colspan="1">32/190</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Colorectal carcinoma</td>
              <td align="left" rowspan="1" colspan="1">12.3%</td>
              <td align="left" rowspan="1" colspan="1">19/154</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Hepatocellular carcinoma</td>
              <td align="left" rowspan="1" colspan="1">14.9%</td>
              <td align="left" rowspan="1" colspan="1">22/148</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Bladder cancer</td>
              <td align="left" rowspan="1" colspan="1">3.8%</td>
              <td align="left" rowspan="1" colspan="1">5/131</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Cholangiocarcinoma</td>
              <td align="left" rowspan="1" colspan="1">10.3%</td>
              <td align="left" rowspan="1" colspan="1">13/126</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Clear cell renal cell carcinoma</td>
              <td align="left" rowspan="1" colspan="1">3.7%</td>
              <td align="left" rowspan="1" colspan="1">4/108</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Cervical cancer</td>
              <td align="left" rowspan="1" colspan="1">9.8%</td>
              <td align="left" rowspan="1" colspan="1">10/102</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Pancreatic cancer</td>
              <td align="left" rowspan="1" colspan="1">5.0%</td>
              <td align="left" rowspan="1" colspan="1">5/101</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Breast fibroepithelial tumors</td>
              <td align="left" rowspan="1" colspan="1">4.4%</td>
              <td align="left" rowspan="1" colspan="1">3/68</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Lung cancer</td>
              <td align="left" rowspan="1" colspan="1">9.4%</td>
              <td align="left" rowspan="1" colspan="1">5/53</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Oral squamous cell carcinoma</td>
              <td align="left" rowspan="1" colspan="1">14%</td>
              <td align="left" rowspan="1" colspan="1">7/50</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Lymphoma</td>
              <td align="left" rowspan="1" colspan="1">8%</td>
              <td align="left" rowspan="1" colspan="1">2/25</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Prostate cancer</td>
              <td align="left" rowspan="1" colspan="1">10%</td>
              <td align="left" rowspan="1" colspan="1">2/20</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Follicular thyroid carcinoma</td>
              <td align="left" rowspan="1" colspan="1">5.6%</td>
              <td align="left" rowspan="1" colspan="1">1/18</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Hepatoblastoma</td>
              <td align="left" rowspan="1" colspan="1">16.7%</td>
              <td align="left" rowspan="1" colspan="1">1/6</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Acute myeloid leukemia</td>
              <td align="left" rowspan="1" colspan="1">25%</td>
              <td align="left" rowspan="1" colspan="1">2/5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Ovarian serous carcinoma</td>
              <td align="left" rowspan="1" colspan="1">25%</td>
              <td align="left" rowspan="1" colspan="1">1/4</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Cervical intraepithelial neoplasia</td>
              <td align="left" rowspan="1" colspan="1">2.0%</td>
              <td align="left" rowspan="1" colspan="1">1/51</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Esophageal precancerous lesion</td>
              <td align="left" rowspan="1" colspan="1">8.3%</td>
              <td align="left" rowspan="1" colspan="1">1/12</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Other</td>
              <td align="left" rowspan="1" colspan="1">2.4%</td>
              <td align="left" rowspan="1" colspan="1">3/125</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s5-s3">
      <title>Identification of pathogenic germline variants</title>
      <p>The discovered germline variants were systematically compared against the dbSNP database
(<xref rid="R15" ref-type="bibr">15</xref>), the Genome Aggregation Database (gnomAD),
and the ClinVar database (<xref rid="R16" ref-type="bibr">16</xref>). All of the
identified variants had been reported in dbSNP. We next analyzed the cancer contributing
risk of these 233 germline variants discovered in different populations using gnomAD,
which is a collection of germ cell mutations that can be used as a reference with data
from different ethnicities, including ALL (world), AFR (African), AMR (Admixed American),
ASJ (Ashkenazi Jewish), EAS (East Asian), FIN (Finnish), NFE (non-Finnish European), OTH
(other) and SAS (South Asian). Except for variant data not given in gnomAD, odds ratio
analysis of all the discovered variants reached a significant level as candidates for
cancer susceptibility variants.</p>
      <p>For clinical annotation of the COGVIC variants, we resorted to the ClinVar database, a
standard, credible, and stable genetic variation-clinical phenotype association database.
When inquiring about their clinical significance, we found that 82 out of 233 (35%)
identified variants were not reported in the ClinVar database and that only 15 out of 233
(6.4%) variants were exactly matched with cancer predisposition. Furthermore, we found
that some of the pathogenic variants we identified were associated in Caucasian subjects
with benign diseases, such as deafness and benign recurrent intrahepatic cholestasis.</p>
      <p>A total of 233 COGVIC variants were mapped to 89 genes. A list of the potential
pathogenic variants and their characteristics can be accessed on the download page of the
COGVIC database. Forty (17%) of these variants were associated with different cancer types
in the East Asian population. For example, the variant rs62625308 (<xref rid="R17" ref-type="bibr">17</xref>) was reported to be associated with esophageal squamous cancer in a
Chinese cohort but was associated with breast or ovarian cancer in the ClinVar database.
Based on a further literature review for each COGVIC variant, rs28934578 was identified as
a pathogenic variant of malignant esophageal tumors in both our dataset and the ClinVar
database and reported as a variant significantly associated with the risk of breast cancer
in an Indian cohort (<xref rid="R18" ref-type="bibr">18</xref>). These findings suggest
that the COGVIC variants are potential pathogenic or likely pathogenic variants in the
East Asian population. We also found an overall rate of 9.7% (233 cancer-associated
variants in 2401 samples) pathogenic variants in the East Asian cohort and approximately
4.1% pathogenic variants and 3.8% likely pathogenic variants in the TCGA cohort (<xref rid="R1" ref-type="bibr">1</xref>).</p>
    </sec>
    <sec id="s5-s4">
      <title>Differences in potential pathogenic genes between ethnicities</title>
      <p>Our analysis showed that the enriched genes harboring pathogenic or likely pathogenic
variants differed between the COGVIC East Asian population and TCGA Caucasian cohorts.
Regarding pathogenic potency, we identified germline mutations that might strongly
increase the risk of cancer susceptibility in East Asian populations, such as variants in
<xref rid="T2" ref-type="table">Table 2</xref>. Genes with germline variants were not
frequently reported as cancer predisposing genes in Caucasian cohorts. Furthermore, the
top five most frequent genes with germline variants in East Asian subjects were
<italic toggle="yes">BRCA2</italic> (8.2%), <italic toggle="yes">MCM2</italic> (6.0%), <italic toggle="yes">ATM</italic>
(4.7%), <italic toggle="yes">ERBB3</italic> (4.7%) and <italic toggle="yes">RHOA</italic> (3.4%) (<xref rid="F2" ref-type="fig">Figure 2</xref>). In comparison, the top five most frequent
genes in the TCGA Caucasian cohort with pathogenic or likely pathogenic variants were
<italic toggle="yes">BRCA1</italic> (<italic toggle="yes">n</italic> = 72/636, 11.3%), <italic toggle="yes">BRCA2</italic>
(<italic toggle="yes">n</italic> = 63/636, 9.9%), <italic toggle="yes">ATM</italic> (<italic toggle="yes">n</italic> = 44/636,
6.9%), <italic toggle="yes">CHEK2</italic> (<italic toggle="yes">n</italic> = 27/636, 4.2%) and
<italic toggle="yes">BRIP1</italic> (<italic toggle="yes">n</italic> = 21/636, 3.3%). Twenty-four genes overlapped
between the two cohorts: <italic toggle="yes">APC, ATM, BRCA1, BRCA2, BRIP1, CDKN1B, CDKN2A, COL7A1,
EPCAM, HNF1A, MLH1, MUTYH, PALB2, PMS2, PTCH1, PTPN11, RAD50, RECQL4, SDHB, SERPINA1,
SMAD4, TP53, TSC1</italic> and <italic toggle="yes">WRN</italic>, suggesting that these genes
contribute to cancer susceptibility worldwide (see the Venn diagram in <xref rid="F2" ref-type="fig">Figure 2</xref>). We further observed that the genes with
germline variants in the East Asian and TCGA Caucasian cohorts have different gene
ontologies, reflecting the biological functions, pathways, or cellular localizations of
these genes. In the COGVIC cohort, variants were enriched in genes functioning in the
biological process of ontology and were involved in adenyl ribonucleotide binding, drug
binding, and double-strand break repair (Figure S1a). Interestingly, the located genes
with pathogenic or likely pathogenic variants in the TCGA Caucasian cohort were associated
with DNA repair, cellular response to DNA damage stimulus, and DNA metabolic process
pathways (Figure S1b). Additionally, KEGG pathway analysis revealed common cancer pathways
in both the COGVIC cohort and the TCGA cohort, such as pathways in cancer, Fanconi anemia
pathway, gastric cancer and colorectal cancer (Figure S1c and d). These findings indicate
that further studies of the impacts of cancer-predisposing genes in Asian populations are
needed.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2.</label>
        <caption>
          <p>Germline variants that might strongly increase the risk of cancer susceptibility in
East Asian populations</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1">Gene</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">East_Asian_OR</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">95% CI</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">World_OR</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">95% CI</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">MCM2</td>
              <td align="left" rowspan="1" colspan="1">22.7</td>
              <td align="left" rowspan="1" colspan="1">[2.7, 188.2]</td>
              <td align="left" rowspan="1" colspan="1">309.6</td>
              <td align="left" rowspan="1" colspan="1">[31.5, 3048.8]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ERBB3</td>
              <td align="left" rowspan="1" colspan="1">11.3</td>
              <td align="left" rowspan="1" colspan="1">[1.2, 108.8]</td>
              <td align="left" rowspan="1" colspan="1">154.7</td>
              <td align="left" rowspan="1" colspan="1">[11.3, 2111.6]</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">CUL7</td>
              <td align="left" rowspan="1" colspan="1">11.3</td>
              <td align="left" rowspan="1" colspan="1">[1.2, 108.8]</td>
              <td align="left" rowspan="1" colspan="1">77.3</td>
              <td align="left" rowspan="1" colspan="1">[15.1, 395.8]</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <fig position="float" id="F2" fig-type="figure">
        <label>Figure 2.</label>
        <caption>
          <p>Genes with pathogenic variants identified in the COGVIC and TCGA cohorts.
Distribution of the variants among 153 genes in both cohorts. The number of cases with
pathogenic variants by gene in the TCGA database (green upper bars) is compared with
those in the East Asian population (blue lower bars). Differences between the
databases are indicated by asterisks above the gene name (when the number of TCGA
cases is greater) or below the gene name (when the number of cases for the gene in the
East Asian population is greater). The numbers in brackets beside the gene name are
consistent with this system, i.e. asterisks above the number in the bracket indicate
the number of TCGA cases, while asterisks below it indicate the number of cases in the
East Asian population. The Venn diagram shows 64 genes with mutations unique to TCGA,
65 genes with mutations unique to the East Asian population and 24 genes with
mutations detected in the two populations.</p>
        </caption>
        <graphic xlink:href="baab075f2" position="float"/>
      </fig>
    </sec>
    <sec id="s5-s5">
      <title>The spectrum of <italic toggle="yes">BRCA2</italic> variants in East Asian and Caucasian
cohorts</title>
      <p>We observed that the identified <italic toggle="yes">BRCA2</italic> variants were mainly located at
exons 10 and 11 in all three cohorts, suggesting that this gene likely affects cancer
susceptibility across the worldwide population (<xref rid="F3 F3" ref-type="fig">Figure 3A
and B</xref> and <xref rid="T3" ref-type="table">Table 3</xref>). The top two exonic
function changes in these variants were stop-gain and frameshift deletion. Of note, we did
not find <italic toggle="yes">BRCA2</italic> variants in common between the East Asian (COGVIC and TCGA
East Asian cohort) and TCGA Caucasian cohorts (<xref rid="F3" ref-type="fig">Figure
3C</xref>), suggesting that each population has ethnic-specific variants in the
<italic toggle="yes">BRCA2</italic> gene.</p>
      <fig position="float" id="F3" fig-type="figure">
        <label>Figure 3.</label>
        <caption>
          <p>Distribution of identified pathogenic variants of BRCA2 around the world. (A) The
proportion of BRCA2 variants in different exons in Asian cases from the COGVIC and
TCGA cohorts. The colors represent different exons, e.g. exon 1 and exon 2. (B) The
proportion of BRCA2 variants in different exons in the TCGA Caucasian cohort. The
colors are consistent with the exons shown in A. (C) All variants placed on the BRCA2
gene map. The numbers indicate the exon numbers. The detected variants are indicated
by arrows. Red arrows represent the East Asian population, whereas the green arrows
represent the Caucasian population. There are two splicing mutations, one between
exons 1 and 2 and one between exons 7–8.</p>
        </caption>
        <graphic xlink:href="baab075f3" position="float"/>
      </fig>
      <table-wrap position="float" id="T3">
        <label>Table 3.</label>
        <caption>
          <p>The function and distribution of pathogenic BRCA2 variants in the COGVIC and TCGA
cohorts</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th valign="bottom" align="left" rowspan="1" colspan="1"/>
              <th valign="bottom" align="left" rowspan="1" colspan="1"/>
              <th valign="bottom" align="left" rowspan="1" colspan="1">COGVIC and TCGA Asian cohort</th>
              <th valign="bottom" align="left" rowspan="1" colspan="1">TCGA Caucasian cohort</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Exonic functional change</td>
              <td align="left" rowspan="1" colspan="1">Number of BRCA2 variants</td>
              <td align="left" rowspan="1" colspan="1">23</td>
              <td align="left" rowspan="1" colspan="1">63</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Synonymous SNV</td>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Frameshift insertion</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Nonsynonymous SNV</td>
              <td align="left" rowspan="1" colspan="1">10</td>
              <td align="left" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Unknown</td>
              <td align="left" rowspan="1" colspan="1">3</td>
              <td align="left" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Stop gain</td>
              <td align="left" rowspan="1" colspan="1">11</td>
              <td align="left" rowspan="1" colspan="1">12</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Nonframeshift deletion</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Nonframeshift insertion</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Frameshift deletion</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">40</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Frameshift substitution</td>
              <td align="left" rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Pathogenicity classification</td>
              <td align="left" rowspan="1" colspan="1">Benign</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Benign/likely benign</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Likely benign</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Conflicting interpretations of pathogenicity</td>
              <td align="left" rowspan="1" colspan="1">11</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Uncertain significance</td>
              <td align="left" rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Pathogenic/likely pathogenic</td>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Pathogenic</td>
              <td align="left" rowspan="1" colspan="1">9</td>
              <td align="left" rowspan="1" colspan="1">61</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Unknown</td>
              <td align="left" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1">Number of variants</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Variants in BRCA2 exon</td>
              <td align="left" rowspan="1" colspan="1">Exon 1</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 2</td>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 3</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 4</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 5</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 6</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 7</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 8</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 9</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 10</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">4</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 11</td>
              <td align="left" rowspan="1" colspan="1">12</td>
              <td align="left" rowspan="1" colspan="1">37</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 12</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 13</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 14</td>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 15</td>
              <td align="left" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 16</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 17</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 18</td>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 19</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 20</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 21</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 22</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 23</td>
              <td align="left" rowspan="1" colspan="1">2</td>
              <td align="left" rowspan="1" colspan="1">2</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 24</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 25</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 26</td>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 27</td>
              <td align="left" rowspan="1" colspan="1">4</td>
              <td align="left" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Variants in BRCA2 splicing site</td>
              <td align="left" rowspan="1" colspan="1">Exon 1-2</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">Exon 7-8</td>
              <td align="left" rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s5-s6">
      <title>Overview of the COGVIC database</title>
      <p>We built a user-friendly online tool for deposition, retrieval, and analysis of
pathogenic and likely pathogenic germline mutations identified in the study (<xref rid="F4" ref-type="fig">Figure 4</xref>). In the search section, users can query the
database in five different ways: (i) Gene: searches by the gene symbol; (ii) Chromosome
ID: searches using the chromosome ID, user can choose by clicking the chromosome ideogram
graphic; (iii) SNP ID: searches with the rs# from dbSNP; (iv) Population: allows selection
of population group (0: non-EastAsian; other: East Asian); (v) Disease: search by disease
name related to mutation. The search terms are not case sensitive. Next, in the ‘browse’
section, users can consider all the information of germline mutations and can see the
specific information of the mutation by clicking on the mutation of interest. The
identified cancer pathogenic and likely pathogenic germline mutations can be retrieved
from the download section, and newly submitted cancer pathogenic germline mutations will
be updated after confirmation by a COGVIC administrator. Developers can request access to
COGVIC data with API. An access license and access document can be obtained in this
section.</p>
      <fig position="float" id="F4" fig-type="figure">
        <label>Figure 4.</label>
        <caption>
          <p>The main functions of the COGVIC database. This figure shows examples of outputs to
specific search queries. Search by gene: results of search by gene symbol; Search by
chr: search by chromosome ID; Users can choose by clicking the chromosome ideogram
graphic. Search by rsID: uses SNP rs# from dbSNP; Search by population: retrieves
population-specific information mutation frequency (0: not Asian; other: Asian);
Search by disease: search with disease names finds associated mutations.</p>
        </caption>
        <graphic xlink:href="baab075f4" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="s6">
    <title>Discussion</title>
    <p>The number of identified genes with germline mutations is a result of both pedigree
analysis of target genes and populational gene analysis by NGS. Recent studies show that
tumor susceptibility may differ between East Asians and Caucasians due to genetic
differences (<xref rid="R7" ref-type="bibr">7</xref>). With increasing exome and WGS data
published for the East Asian population, we have performed large-scale analyses of their
germline variants. All these variants can be found using the online tools we developed and
have made publicly available (<ext-link xlink:href="http://www.cogvic.vip/" ext-link-type="uri">http://www.cogvic.vip/</ext-link>). We identified 233 variants across 89 genes associated
with cancer risk in this geographical region, with 24 genes being common to both East Asian
and Caucasian populations. Importantly, our data showed that 9.7% of patients with cancer
carry germline cancer susceptibility variants. This percentage was comparable to the 7.9% in
the TCGA pancancer cohort. Because the majority of pathogenic variants in genes differed
between the two populations, ethnic differences should be considered a factor in the
investigation of cancer susceptibility genes.</p>
    <p>Tumor onset may be related to ethnic differences due to genetic background (<xref rid="R7" ref-type="bibr">7</xref>). A previous study compared WES data from Asian (Chinese
and Vietnamese) subjects with those from European Caucasians, finding seven genes with a
high mutation rate based on a comparison with TCGA data, so these can be used for early
screening of esophageal cancer risk in that geographical region (<xref rid="R19" ref-type="bibr">19</xref>). Among our identified genes with germline variants, only 27%
overlapped with genes in the TCGA dataset. Biological function analysis indicated that these
genes are associated with cancer predisposition in both cohorts. <italic toggle="yes">BRCA2</italic>
harbored the most pathogenic or likely pathogenic variants in the East Asian cohort. Cancer
pathogenic variants in <italic toggle="yes">BRCA2</italic> did not overlap significantly across cancer
types between the COGVIC and TCGA cohorts, and it will be of interest to see if this will be
confirmed in larger cohorts. Our findings suggest that the distribution of pathogenic or
likely pathogenic germline mutations across cancers is different in the East Asian and TCGA
Caucasian cohorts, providing evidence that the reference gene panel for genetic consultation
should consider ethnicity as a factor.</p>
    <p>Although some <italic toggle="yes">BRCA2</italic> variants were shared between Asian and Caucasian
populations, the pathogenic role of a SNP can be ethnically specific, namely a carcinogenic
SNP in European populations may have benign or even protective effects in Asian populations
(<xref rid="R20" ref-type="bibr">20</xref>). However, the challenge of understanding the
difference arises from the lack of data in these populations and previous findings from
genome-wide association studies. Currently, our in-depth investigation of
<italic toggle="yes">BRCA2</italic> variants revealed that <italic toggle="yes">BRCA2</italic> variants were not
shared between ethnicities. Based on multiple cancer analyses, we postulated that the
differences in the frequency and pathogenic role of variants between populations may not be
limited to breast cancer. We further confirmed that common exons of
<italic toggle="yes">BRCA2</italic>-harboring pathogenic variants are exons 10 and 11, as a previous
study summarized (<xref rid="R21" ref-type="bibr">21</xref>). This may result from an
increased probability of mutation due to the larger genomic size of these exons compared
with the other exons in <italic toggle="yes">BRCA2</italic>. Therefore, SNP array-based cancer screening
should include the SNPs we identified and consider ethnicity an important factor to avoid
false-negative results.</p>
    <p>There are some limitations of this study. First, although the study included a large-scale
analysis, the open-access exon or WGS databases did not include data from all countries in
the East Asian region either because these data have not been generated or are not publicly
accessible. Thus, population bias may exist in our study. The second limitation is that, due
to access issues, germline variants in the TCGA cohort cannot be downloaded; thus, the two
datasets can only be indirectly compared. These problems confirm the importance of public
access to germline variants under the context of ethical approval and personal
confidentiality. Finally, the identified germline variants should be validated
experimentally and supported by more clinical data in the future. We will update germline
variants in the online COGVIC database annually as new data are published.</p>
  </sec>
  <sec id="s7">
    <title>Conclusions</title>
    <p>Taken together, our results provide additional germline variants for genetic testing in the
assessment of cancer risk, especially for East Asian countries and countries with people of
East Asian descent. The results also support the notion of ethnicity-specific cancer
susceptibility genes and provide targets that warrant further research for cancer prevention
in different regions.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>baab075_Supp</label>
      <media xlink:href="baab075_supp.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>We thank the China Scholarship Council for granting a Ph.D. scholarship to Xiaoshun Shi
(201808440513).</p>
  </ack>
  <sec id="s8">
    <title>Supplementary data</title>
    <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available
at <italic toggle="yes">Database</italic> Online.</p>
  </sec>
  <sec id="s9">
    <title>Funding</title>
    <p>Research Initiative Fund of Southern Hospital 2018 (C1051325); National Natural Science
Foundation of China (81902319); Major Science and Technology Planning Project of Guangdong
Province (2017B020226005); Science and Technology Program of Guangzhou (201903010003).</p>
  </sec>
  <sec id="s10">
    <title>Conflict of interest</title>
    <p>A.M.C. owns Guangzhou Mendel Genomics and Medical Technology Co. K.H., Z.Z., Z.C. are
employees of the company, who provided material support for this project. The database was
built for public searching of germline pathogenic variants in East Asian pancancer patients.
The Guangzhou Mendel Genomics and Medical Technology Co. declared no purpose for the
commercial use of the database.</p>
  </sec>
  <sec sec-type="data-availability" id="s11">
    <title>Data availability</title>
    <p>All the data are available online and documented at <ext-link xlink:href="http://www.cogvic.vip/" ext-link-type="uri">http://www.cogvic.vip/</ext-link>.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="R1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>K.L.</given-names></string-name>, <string-name><surname>Mashl</surname>
 <given-names>R.J.</given-names></string-name>, <string-name><surname>Wu</surname>
 <given-names>Y.</given-names></string-name></person-group>  <etal>et al.</etal>
(<year>2018</year>) <article-title>Pathogenic germline variants in 10,389 adult
cancers</article-title>. <source><italic toggle="yes">Cell</italic></source>, <volume>173</volume>,
<fpage>355</fpage>–<lpage>370.e14</lpage>.<pub-id pub-id-type="pmid">29625052</pub-id></mixed-citation>
    </ref>
    <ref id="R2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>C.</given-names></string-name>,
<string-name><surname>Xie</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Wendl</surname><given-names>M.C.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2015</year>) <article-title>Patterns and functional
implications of rare germline variants across 12 cancer types</article-title>.
<source><italic toggle="yes">Nat. Commun.</italic></source>, <volume>6</volume>,
<page-range>10086</page-range>.</mixed-citation>
    </ref>
    <ref id="R3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname><given-names>H.-M.</given-names></string-name>,
<string-name><surname>Li</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Black</surname><given-names>M.H.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2019</year>) <article-title>Association of breast and
ovarian cancers with predisposition genes identified by large-scale
sequencing</article-title>. <source><italic toggle="yes">JAMA Oncol.</italic></source>,
<volume>5</volume>, <fpage>51</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">30128536</pub-id></mixed-citation>
    </ref>
    <ref id="R4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Panou</surname><given-names>V.</given-names></string-name>,
<string-name><surname>Gadiraju</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Wolin</surname><given-names>A.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2018</year>) <article-title>Frequency of germline mutations
in cancer susceptibility genes in malignant mesothelioma</article-title>.
<source><italic toggle="yes">J. Clin. Oncol.</italic></source>, <volume>36</volume>,
<fpage>2863</fpage>–<lpage>2871</lpage>.<pub-id pub-id-type="pmid">30113886</pub-id></mixed-citation>
    </ref>
    <ref id="R5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rahman</surname><given-names>N.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Realizing the promise of cancer
predisposition genes</article-title>. <source><italic toggle="yes">Nature</italic></source>,
<volume>505</volume>, <fpage>302</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="pmid">24429628</pub-id></mixed-citation>
    </ref>
    <ref id="R6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leinonen</surname><given-names>R.</given-names></string-name>,
<string-name><surname>Sugawara</surname><given-names>H.</given-names></string-name>,
<string-name><surname>Shumway</surname><given-names>M.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2011</year>) <article-title>The sequence read
archive</article-title>. <source><italic toggle="yes">Nucleic Acids Res.</italic></source>,
<volume>39</volume>, <fpage>D19</fpage>–<lpage>D21</lpage>.<pub-id pub-id-type="pmid">21062823</pub-id></mixed-citation>
    </ref>
    <ref id="R7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thompson</surname><given-names>C.A.</given-names></string-name>,
<string-name><surname>Gomez</surname><given-names>S.L.</given-names></string-name>,
<string-name><surname>Hastings</surname><given-names>K.G.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2016</year>) <article-title>The burden of cancer in Asian
Americans: a report of national mortality trends by Asian ethnicity</article-title>.
<source><italic toggle="yes">Cancer Epidemiol. Biomark. Prev.</italic></source>,
<volume>25</volume>, <fpage>1371</fpage>–<lpage>1382</lpage>.</mixed-citation>
    </ref>
    <ref id="R8">
      <label>8.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Andrews</surname><given-names>S.</given-names></string-name></person-group> (<year>2010</year>) <source><italic toggle="yes">FastQC: A Quality Control Tool for
High Throughput Sequence Data</italic></source>. <ext-link xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/" ext-link-type="uri">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>.
<publisher-loc>Boston, MA</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="R9">
      <label>9.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Krueger</surname><given-names>F.</given-names></string-name></person-group> (<year>2015</year>) <source><italic toggle="yes">A Wrapper Tool around Cutadapt and
FastQC to Consistently Apply Quality and Adapter Trimming to FastQ
Files</italic></source>. <publisher-name>Babraham Institute</publisher-name>,
<publisher-loc>Cambridge, UK</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="R10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langmead</surname><given-names>B.</given-names></string-name> and
<string-name><surname>Salzberg</surname><given-names>S.L.</given-names></string-name></person-group>
(<year>2012</year>) <article-title>Fast gapped-read alignment with Bowtie
2</article-title>. <source><italic toggle="yes">Nat. Methods</italic></source>, <volume>9</volume>,
<fpage>357</fpage>–<lpage>359</lpage>.<pub-id pub-id-type="pmid">22388286</pub-id></mixed-citation>
    </ref>
    <ref id="R11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koboldt</surname><given-names>D.C.</given-names></string-name>,
<string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>,
<string-name><surname>Larson</surname><given-names>D.E.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2012</year>) <article-title>VarScan 2: somatic mutation and
copy number alteration discovery in cancer by exome sequencing</article-title>.
<source><italic toggle="yes">Genome Res.</italic></source>, <volume>22</volume>,
<fpage>568</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">22300766</pub-id></mixed-citation>
    </ref>
    <ref id="R12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>,
<string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name>,
<string-name><surname>Schlesinger</surname><given-names>F.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2013</year>) <article-title>STAR: ultrafast universal
RNA-seq aligner</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>,
<volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
    </ref>
    <ref id="R13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>H.</given-names></string-name>,
<string-name><surname>Handsaker</surname><given-names>B.</given-names></string-name>,
<string-name><surname>Wysoker</surname><given-names>A.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2009</year>) <article-title>The sequence alignment/map
format and SAMtools</article-title>. <source><italic toggle="yes">Bioinformatics</italic></source>,
<volume>25</volume>, <fpage>2078</fpage>–<lpage>2079</lpage>.<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
    </ref>
    <ref id="R14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>K.</given-names></string-name>,
<string-name><surname>Li</surname><given-names>M.</given-names></string-name>,
<string-name><surname>Hakonarson</surname><given-names>H.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2010</year>) <article-title>ANNOVAR: functional annotation
of genetic variants from high-throughput sequencing data</article-title>.
<source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>38</volume>,
<page-range>e164</page-range>.</mixed-citation>
    </ref>
    <ref id="R15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wheeler</surname><given-names>D.L.</given-names></string-name>,
<string-name><surname>Barrett</surname><given-names>T.</given-names></string-name>,
<string-name><surname>Benson</surname><given-names>D.A.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2007</year>) <article-title>Database resources of the
national center for biotechnology information</article-title>. <source><italic toggle="yes">Nucleic
Acids Res.</italic></source>, <volume>35</volume>,
<fpage>D5</fpage>–<lpage>D12</lpage>.<pub-id pub-id-type="pmid">17170002</pub-id></mixed-citation>
    </ref>
    <ref id="R16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Landrum</surname><given-names>M.J.</given-names></string-name>,
<string-name><surname>Lee</surname><given-names>J.M.</given-names></string-name>,
<string-name><surname>Riley</surname><given-names>G.R.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2014</year>) <article-title>ClinVar: public archive of
relationships among sequence variation and human phenotype</article-title>.
<source><italic toggle="yes">Nucleic Acids Res.</italic></source>, <volume>42</volume>,
<fpage>D980</fpage>–<lpage>D985</lpage>.<pub-id pub-id-type="pmid">24234437</pub-id></mixed-citation>
    </ref>
    <ref id="R17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lin</surname><given-names>D.-C.</given-names></string-name>,
<string-name><surname>Hao</surname><given-names>-J.-J.</given-names></string-name>,
<string-name><surname>Nagata</surname><given-names>Y.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2014</year>) <article-title>Genomic and molecular
characterization of esophageal squamous cell carcinoma</article-title>.
<source><italic toggle="yes">Nat. Genet.</italic></source>, <volume>46</volume>,
<fpage>467</fpage>–<lpage>473</lpage>.<pub-id pub-id-type="pmid">24686850</pub-id></mixed-citation>
    </ref>
    <ref id="R18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Damineni</surname><given-names>S.</given-names></string-name>,
<string-name><surname>Rao</surname><given-names>V.R.</given-names></string-name>,
<string-name><surname>Kumar</surname><given-names>S.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2014</year>) <article-title>Germline mutations of TP53 gene
in breast cancer</article-title>. <source><italic toggle="yes">Tumour Biol.</italic></source>,
<volume>35</volume>, <fpage>9219</fpage>–<lpage>9227</lpage>.<pub-id pub-id-type="pmid">24929325</pub-id></mixed-citation>
    </ref>
    <ref id="R19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname><given-names>J.</given-names></string-name>,
<string-name><surname>Chen</surname><given-names>H.</given-names></string-name>,
<string-name><surname>Zhou</surname><given-names>D.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2017</year>) <article-title>Comparative genomic analysis of
esophageal squamous cell carcinoma between Asian and Caucasian patient
populations</article-title>. <source><italic toggle="yes">Nat. Commun.</italic></source>,
<volume>8</volume>, <page-range>1533</page-range>.</mixed-citation>
    </ref>
    <ref id="R20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yap</surname><given-names>Y.-S.</given-names></string-name>,
<string-name><surname>Lu</surname><given-names>Y.-S.</given-names></string-name>,
<string-name><surname>Tamura</surname><given-names>K.</given-names></string-name></person-group>
 <etal>et al.</etal> (<year>2019</year>) <article-title>Insights into breast cancer in
the east vs the west: a review</article-title>. <source><italic toggle="yes">JAMA
Oncol.</italic></source>, <volume>5</volume>,
<fpage>1489</fpage>–<lpage>1496</lpage>.<pub-id pub-id-type="pmid">31095268</pub-id></mixed-citation>
    </ref>
    <ref id="R21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karami</surname><given-names>F.</given-names></string-name> and
<string-name><surname>Mehdipour</surname><given-names>P.</given-names></string-name></person-group>
(<year>2013</year>) <article-title>A comprehensive focus on global spectrum of BRCA1 and
BRCA2 mutations in breast cancer</article-title>. <source><italic toggle="yes">BioMed Res.
Int.</italic></source>, <volume>2013</volume>,
<page-range>928562</page-range>.</mixed-citation>
    </ref>
  </ref-list>
</back>
